ALXO ▼ -0.8% - ALX Oncology Holdings Inc.
$ALXO - ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
28-SEP-2026 08:02 AM ET
Share this post
More filings for $ALXO
ALXO ▼ -1.0% - ALX Oncology Holdings Inc.Sep 2, 2026ALXO - ALX Oncology Holdings Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$ALXO SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $ALXO filing history →💬 Comments
Loading comments…
Leave a comment